Vinayak Doraiswamy Atri Cure, Inc. (ATRC) insider trading activity
Vinayak Doraiswamy is Chief Scientific Officer of AtriCure, Inc.. Currently has a direct ownership of 73,550 shares of ATRC, which is worth approximately $2.54 Million. The most recent transaction as insider was on May 28, 2025, when has been sold 2,500 shares (Common Stock) at a price of $33.44 per share, resulting in proceeds of $83,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
73.6K
3.29%
3M change
24.5%
12M change
Total Value Held
$2.54 Million
Vinayak Doraiswamy Transaction History
VD
Vinayak Doraiswamy
Chief Scientific Officer
Mason, OH